These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9533061)

  • 41. Colitis induced by Clostridium difficile.
    Bartlett JG; Chang T; Taylor NS; Onderdonk AB
    Rev Infect Dis; 1979; 1(2):370-8. PubMed ID: 549188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
    Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E; Alcázar Montero MS; Navarro Gaspar C; Gimeno Aranguez M
    An Med Interna; 2002 Dec; 19(12):637-9. PubMed ID: 12593034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
    Bishara J; Peled N; Pitlik S; Samra Z
    J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis.
    Fischbach F; Petersen EE; Weissenbacher ER; Martius J; Hosmann J; Mayer H
    Obstet Gynecol; 1993 Sep; 82(3):405-10. PubMed ID: 8355942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of Clostridium difficile toxins A and B and Clostridium perfringens enterotoxin A in stool samples of patients with antibiotic-associated diarrhea.
    Heimesaat MM; Granzow K; Leidinger H; Liesenfeld O
    Infection; 2005 Oct; 33(5-6):340-4. PubMed ID: 16258864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The treatment of bacterial vaginosis with Dalacin V cream].
    POrozhanova V; Bozhinova S
    Akush Ginekol (Sofiia); 2000; 39(2):34-5. PubMed ID: 10948619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].
    Jakobsen L; Tvede M
    Ugeskr Laeger; 2006 Apr; 168(17):1634-5. PubMed ID: 16674873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea.
    Peled N; Pitlik S; Samra Z; Kazakov A; Bloch Y; Bishara J
    Infect Control Hosp Epidemiol; 2007 Apr; 28(4):377-81. PubMed ID: 17385141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
    Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
    Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis.
    Finegold SM
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):87S-91S. PubMed ID: 3698542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diarrhea due to Clostridium difficile toxin in hemato-oncological patients].
    Kerst JM; van der Lelie J; Kuijper EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1137-40. PubMed ID: 11433658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.
    Snydman DR; McDermott LA; Jacobus NV; Thorpe C; Stone S; Jenkins SG; Goldstein EJ; Patel R; Forbes BA; Mirrett S; Johnson S; Gerding DN
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6437-43. PubMed ID: 26239985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clostridium difficile diarrhea: pathogenesis, epidemiology, and treatment.
    Mitty RD; LaMont JT
    Gastroenterologist; 1994 Mar; 2(1):61-9. PubMed ID: 8055233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is Clostridium difficile a pathogen in the newborn intensive care unit? A prospective evaluation.
    Enad D; Meislich D; Brodsky NL; Hurt H
    J Perinatol; 1997; 17(5):355-9. PubMed ID: 9373839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis.
    Hillier S; Krohn MA; Watts DH; Wolner-Hanssen P; Eschenbach D
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):407-13. PubMed ID: 2381617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.
    Bartlett JG; Chang TW; Gurwith M; Gorbach SL; Onderdonk AB
    N Engl J Med; 1978 Mar; 298(10):531-4. PubMed ID: 625309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.